ACTIVE

OOGCHIRURGIE DR. VAN SLYCKEN -DR.CANDAELE

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result273,2 k €+3,4 %over 1 year
Gross margin559 k €+36,5 %over 1 year
Equity604,3 k €+82,5 %over 1 year
Workforce2,3 ETP+64,3 %over 1 year

Identity

Source · BCE/KBO

OOGCHIRURGIE DR. VAN SLYCKEN -DR.CANDAELE is a Private limited company incorporated in 2014. Its main activity is: Specialist medical practice activities. Its registered office is in Gent. It employs on average 2,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0562.965.729
Incorporation
23/09/2014
Legal form
Private limited company
Registered office
Edward Anseeleplein 12
9000 Gent · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
30/06/2025
Average workforce
2,3 ETP
Joint committees (1)
  • 330
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 11 filings

Trend over 11 financial years

20252024202320222021
Income statement
Gross margin559 k €409,4 k €387,3 k €345,6 k €225 k €
EBITDA433,9 k €346,4 k €332,5 k €309,2 k €224,9 k €
Operating result379,5 k €328,5 k €324 k €289,8 k €198,2 k €
Net result273,2 k €264,2 k €245,8 k €220 k €166,1 k €
Balance sheet
Equity604,3 k €331,1 k €666,9 k €421,2 k €201,2 k €
Total assets1,9 M €1,6 M €1,3 M €1,1 M €843,8 k €
Cash281,2 k €822,3 k €953,1 k €716,8 k €395,8 k €
Debts1,3 M €1,2 M €655 k €658,4 k €631,1 k €
Other
Workforce2,3 ETP1,4 ETP1,2 ETP1,4 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

4 active · 4 ended

Active mandates

Arnaud Van Slycken

Director · since 24 juin 2025

Active
Maxim Van Slycken

Director · since 24 juin 2025

Active
Chantal Candaele

Onbekend

Active
Steven Van Slycken

Onbekend

Active

Ended mandates

Chantal Candaele

Director

Ended
Chantal Candaele

Manager

Ended
Steven Van Slycken

Director

Ended
Steven Van Slycken

Manager

Ended

Other companies at this address

Edward Anseeleplein 12 9000 Gent
CompanyCBE no.
Dr. AVS● Active
1023.587.748
DR. VAN SLYCKEN - DR. CANDAELE● Active
0473.812.435
Saeys I. Huisarts● Active
1001.051.381

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/01/202620/01/202530/01/202431/01/202328/01/202223/01/2021
General meeting27/12/202528/12/202430/12/202330/12/202231/12/202128/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202527/12/202523/01/2026DutchPDF
Abridged model30/06/202428/12/202420/01/2025DutchPDF
Abridged model30/06/202330/12/202330/01/2024DutchPDF
Abridged model30/06/202230/12/202231/01/2023DutchPDF
Abridged model30/06/202131/12/202128/01/2022DutchPDF
Abridged model30/06/202028/12/202023/01/2021DutchPDF
Abridged model30/06/201927/12/201913/01/2020DutchPDF
Abridged model30/06/201828/12/201808/01/2019DutchPDF
Micro model30/06/201729/12/201708/01/2018DutchPDF
Abridged model30/06/201630/12/201612/01/2017DutchPDF
Abridged model30/06/201526/12/201513/01/2016DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

4 active · 4 ended

Active mandates

Arnaud Van Slycken

Director · since 24 juin 2025

Active
Maxim Van Slycken

Director · since 24 juin 2025

Active
Chantal Candaele

Onbekend

Active
Steven Van Slycken

Onbekend

Active

Ended mandates

Chantal Candaele

Director

Ended
Chantal Candaele

Manager

Ended
Steven Van Slycken

Director

Ended
Steven Van Slycken

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates21/10/2025
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/06/2021
    WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other03/10/2014
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025273,2 k €↑
  2. 2024
    Annual accounts 2024264,2 k €↑
  3. 2023
    Annual accounts 2023245,8 k €↑
  4. 2022
    Annual accounts 2022220 k €↑
  5. 2021
    Annual accounts 2021166,1 k €↓
  6. 2020
    Annual accounts 2020207,2 k €↑
  7. 2019
    Annual accounts 2019188,6 k €↑
  8. 2018
    Annual accounts 2018144,1 k €↓
  9. 2017
    Annual accounts 2017170,6 k €↓
  10. 2016
    Annual accounts 2016199,3 k €↑
  11. 2015
    Annual accounts 2015136,6 k €
  12. 23/09/2014
    IncorporationPrivate limited company